Exact Mass: 349.1249

Exact Mass Matches: 349.1249

Found 146 metabolites which its exact mass value is equals to given mass value 349.1249, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fentrazamide

4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazole-1-carboxamide

C16H20ClN5O2 (349.1305)


   

Voriconazole

(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol

C16H14F3N5O (349.115)


Voriconazole (Vfend, Pfizer) is a triazole antifungal medication used to treat serious fungal infections. It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-(Biaryl)carbapenems

2-(Biaryl)carbapenems

C21H19NO4 (349.1314)


   

Mitomycin A

SCHEMBL183170

C16H19N3O6 (349.1274)


A member of the family of mitomycins that exhibits antibiotic and antitumour properties as well as a high level of toxicity. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins

   

Azasetron

N-(1-azabicyclo(2.2.2)Oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride

C17H20ClN3O3 (349.1193)


   

Dihydrochelerythrine

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1,3,8,10,12,14,16,18-octaene

C21H19NO4 (349.1314)


Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

Emate

(13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) sulfamate

C18H23NO4S (349.1348)


   

gamma-Glutamyl-5-hydroxytryptophan

4-Amino-4-{[1-carboxy-2-(5-hydroxy-1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}butanoate

C16H19N3O6 (349.1274)


   

Glutathione monoisopropyl ester

2-amino-4-[(1-{[2-oxo-2-(propan-2-yloxy)ethyl]carbamoyl}-2-sulfanylethyl)carbamoyl]butanoic acid

C13H23N3O6S (349.1307)


   

Mitomycin A

Azirino[2,3:3,4]pyrrolo[1,2-a]indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-6,8a-dimethoxy-5-methyl-, carbamate (ester)

C16H19N3O6 (349.1274)


   

3-Quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-

3-Quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-

C17H17F2N3O3 (349.1238)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Perampanel

3-(2-Cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one

C23H15N3O (349.1215)


N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

Texaphyrin

13,20,25,26,27-pentaazapentacyclo[20.2.1.1^{3,6}.1^{8,11}.0^{14,19}]heptacosa-1,3,5,7,9,11(26),12,14,16,18,20,22(25),23-tridecaene

C22H15N5 (349.1327)


   

tryptophan glutamate

4-amino-5-{[2-amino-3-(1H-indol-3-yl)propanoyl]peroxy}-5-oxopentanoic acid

C16H19N3O6 (349.1274)


   

Dihydrochelerythrine

1,2-Dimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

C21H19NO4 (349.1314)


Dihydrochelerythrine is a benzophenanthridine alkaloid. Dihydrochelerythrine is a natural product found in Zanthoxylum coriaceum, Zanthoxylum gilletii, and other organisms with data available. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

Dihydronitidine

(1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-

C21H19NO4 (349.1314)


   

Azasetron

Azasetron

C17H20ClN3O3 (349.1193)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   
   

(+)-(6aR,7R,E)-N-(but-2-enoyl)norushinsunine

(+)-(6aR,7R,E)-N-(but-2-enoyl)norushinsunine

C21H19NO4 (349.1314)


   

Buxifoliadine G

Buxifoliadine G

C21H19NO4 (349.1314)


   

Ochotensidine

Ochotensidine

C21H19NO4 (349.1314)


   
   
   
   
   
   
   
   
   
   
   
   

Voriconazole

Voriconazole Vfend

C16H14F3N5O (349.115)


J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(4-(N-Ethyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

(4-(N-Ethyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C16H20BNO5S (349.1155)


   

Oxarbazole

Oxarbazole

C21H19NO4 (349.1314)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

Sematilide hydrochloride

Sematilide hydrochloride

C14H24ClN3O3S (349.1227)


   
   
   

(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C16H14F3N5O (349.115)


   

2-Acetamido-4-fluoro-1,3,6-tri-O-acetyl-2,4-dideoxy-D-glucopyranose

2-Acetamido-4-fluoro-1,3,6-tri-O-acetyl-2,4-dideoxy-D-glucopyranose

C14H20FNO8 (349.1173)


   

rel-(R,R)-Voriconazole

rel-(R,R)-Voriconazole

C16H14F3N5O (349.115)


   

CP-466722

1-(6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine

C17H15N7O2 (349.1287)


   

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride

C15H24ClNO6 (349.1292)


   

Fmoc-(S)-3-Amino-5-hexynoic acid

Fmoc-(S)-3-Amino-5-hexynoic acid

C21H19NO4 (349.1314)


   

N-FMOC-GUVACINE

N-FMOC-GUVACINE

C21H19NO4 (349.1314)


   

1-BOC-4-(4-AMINOPHENYL)PIPERAZINE DIHYDROCHLORIDE

1-BOC-4-(4-AMINOPHENYL)PIPERAZINE DIHYDROCHLORIDE

C15H25Cl2N3O2 (349.1324)


   

(-)-(1s,4r)-n-fmoc-4-aminocyclopent-2-enecarboxylic acid

(-)-(1s,4r)-n-fmoc-4-aminocyclopent-2-enecarboxylic acid

C21H19NO4 (349.1314)


   

(3S,4R)-1-BENZYL-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-BENZYL-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C19H18F3NO2 (349.129)


   

fmoc-(r)-3-amino-5-hexynoic acid

fmoc-(r)-3-amino-5-hexynoic acid

C21H19NO4 (349.1314)


   

4-[Bis(4-methoxyphenyl)amino]benzoic acid

4-[Bis(4-methoxyphenyl)amino]benzoic acid

C21H19NO4 (349.1314)


   

3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

C21H20ClN3 (349.1346)


   

Cinmetacin

1H-Indole-3-aceticacid, 5-methoxy-2-methyl-1-(1-oxo-3-phenyl-2-propen-1-yl)-

C21H19NO4 (349.1314)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

(4-PIPERAZIN-1-YL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER DIHYDROCHLORIDE

(4-PIPERAZIN-1-YL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER DIHYDROCHLORIDE

C15H25Cl2N3O2 (349.1324)


   
   

boc-asp(obzl)-n-carboxyanhydride

boc-asp(obzl)-n-carboxyanhydride

C17H19NO7 (349.1161)


   

Z-ALA-BETA-NAPHTHYL ESTER

Z-ALA-BETA-NAPHTHYL ESTER

C21H19NO4 (349.1314)


   

ent-Voriconazole

ent-Voriconazole

C16H14F3N5O (349.115)


   

(R)-N-Fmoc-2-(2-propynyl)alanine

(R)-N-Fmoc-2-(2-propynyl)alanine

C21H19NO4 (349.1314)


   

tert-butyl 4-(4-aMinophenyl)piperazine-1-carboxylate dihydrochloride

tert-butyl 4-(4-aMinophenyl)piperazine-1-carboxylate dihydrochloride

C15H25Cl2N3O2 (349.1324)


   

Z-3-(1-naphthyl)-L-alanine

Z-3-(1-naphthyl)-L-alanine

C21H19NO4 (349.1314)


   

(S)-N-FMoc-2-(2--propynyl)alanine

(S)-N-FMoc-2-(2--propynyl)alanine

C21H19NO4 (349.1314)


   

Beryllium bis[2-(2-pyridinyl)phenolate]

Beryllium bis[2-(2-pyridinyl)phenolate]

C22H16BeN2O2 (349.1334)


   

Fmoc-L-propargylalanine

Fmoc-L-propargylalanine

C21H19NO4 (349.1314)


   

2-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-nitrobenzoic acid ethyl ester

2-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-nitrobenzoic acid ethyl ester

C16H14F3N5O (349.115)


   

(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol

(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol

C19H16FN5O (349.1339)


   

Mitomycin B

Mitomycin B

C16H19N3O6 (349.1274)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins A member of the family of mitomycins that exhibits antibiotic and antitumour properties.

   

3-(2-Oxolanylmethylthio)-5,6-diphenyl-1,2,4-triazine

3-(2-Oxolanylmethylthio)-5,6-diphenyl-1,2,4-triazine

C20H19N3OS (349.1249)


   

Perampanel

Perampanel

C23H15N3O (349.1215)


N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

AIDS-106788

(1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-1,2-dimethoxy-12-methyl-

C21H19NO4 (349.1314)


Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

3,8,9-Trimethoxy-5-methylbenzo[c]phenanthridin-2-one

3,8,9-Trimethoxy-5-methylbenzo[c]phenanthridin-2-one

C21H19NO4 (349.1314)


   
   

4-amino-5-[2-amino-3-(1H-indol-3-yl)propanoyl]peroxy-5-oxopentanoic acid

4-amino-5-[2-amino-3-(1H-indol-3-yl)propanoyl]peroxy-5-oxopentanoic acid

C16H19N3O6 (349.1274)


   

2-Furanyl-[4-(4-tetrazolo[1,5-a]quinoxalinyl)-1-piperazinyl]methanone

2-Furanyl-[4-(4-tetrazolo[1,5-a]quinoxalinyl)-1-piperazinyl]methanone

C17H15N7O2 (349.1287)


   

3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione

3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione

C17H20ClN3O3 (349.1193)


   

N-[[(2,4-dimethyl-8-quinolinyl)amino]-sulfanylidenemethyl]-4-methylbenzamide

N-[[(2,4-dimethyl-8-quinolinyl)amino]-sulfanylidenemethyl]-4-methylbenzamide

C20H19N3OS (349.1249)


   

6-[(2,5-Dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-triazolo[4,5-d]pyrimidinone

6-[(2,5-Dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-triazolo[4,5-d]pyrimidinone

C19H16FN5O (349.1339)


   

methyl (5E)-5-[(4-hydroxyphenyl)methylidene]-2-methyl-1-(4-methylphenyl)-4-oxopyrrole-3-carboxylate

methyl (5E)-5-[(4-hydroxyphenyl)methylidene]-2-methyl-1-(4-methylphenyl)-4-oxopyrrole-3-carboxylate

C21H19NO4 (349.1314)


   

N-{(1E)-[4-(methylthio)phenyl]methylene}-2-(2-naphthylamino)acetohydrazide

N-{(1E)-[4-(methylthio)phenyl]methylene}-2-(2-naphthylamino)acetohydrazide

C20H19N3OS (349.1249)


   
   
   
   

(2S,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol

(2S,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol

C16H14F3N5O (349.115)


   

4-fluoro-N-[4-(4-methylpiperazin-1-yl)phenyl]benzenesulfonamide

4-fluoro-N-[4-(4-methylpiperazin-1-yl)phenyl]benzenesulfonamide

C17H20FN3O2S (349.126)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(4S,6S,7R)-13-hydroxy-7,11-dimethoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-13-hydroxy-7,11-dimethoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C16H19N3O6 (349.1274)


   

[(4S,6S,7R)-7,13-dihydroxy-11-methoxy-5,12-dimethyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-7,13-dihydroxy-11-methoxy-5,12-dimethyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C16H19N3O6 (349.1274)


   
   

CFMTI

CFMTI

C19H16FN5O (349.1339)


CFMTI inhibits L-glutamate-induced intracellular Ca2+ mobilization in CHO cells expressing human and rat mGluR1a, with IC50s of 2.6 and 2.3 nM, respectively[1].

   

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

C21H19NO4 (349.1314)


   

3,8,9-trimethoxy-5-methylcyclohexa[c]phenanthridin-2-one

3,8,9-trimethoxy-5-methylcyclohexa[c]phenanthridin-2-one

C21H19NO4 (349.1314)


   

[(1s,3s,4s,7r,8s,9r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazapentacyclo[7.4.0.0¹,⁶.0²,⁴.0³,⁷]tridec-11-en-8-yl]methoxycarboximidic acid

[(1s,3s,4s,7r,8s,9r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazapentacyclo[7.4.0.0¹,⁶.0²,⁴.0³,⁷]tridec-11-en-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

[(3s,4s,7r,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazatetracyclo[7.4.0.0²,⁴.0³,⁷]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(3s,4s,7r,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazatetracyclo[7.4.0.0²,⁴.0³,⁷]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C21H19NO4 (349.1314)


   

[(4s,6s,7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4s,6s,7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

[(4s,6s,7r,8s)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4s,6s,7r,8s)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

(2e)-1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

(2e)-1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

C21H19NO4 (349.1314)


   

4-(2-hydroxy-3,4,5-trimethoxybenzoyl)-3-(methylamino)benzene-1,2-diol

4-(2-hydroxy-3,4,5-trimethoxybenzoyl)-3-(methylamino)benzene-1,2-diol

C17H19NO7 (349.1161)


   

[(4r,6r,7s,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4r,6r,7s,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

C21H19NO4 (349.1314)


   

[(7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

6-methyl-6'-methylidene-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxole]

6-methyl-6'-methylidene-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxole]

C21H19NO4 (349.1314)